Gradient Investments’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5
| Closed | -$1K | – | 1301 |
|
|
2021
Q1 | $1K | Hold |
5
| – | – | ﹤0.01% | 1133 |
|
|
2020
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 1112 |
|
|
2020
Q3 | $1K | Sell |
5
-19
| -79% | -$3.8K | ﹤0.01% | 1116 |
|
|
2020
Q2 | $3K | Sell |
24
-183
| -88% | -$22.9K | ﹤0.01% | 857 |
|
|
2020
Q1 | $19K | Sell |
207
-10,621
| -98% | -$975K | ﹤0.01% | 541 |
|
|
2019
Q4 | $1.17M | Buy |
10,828
+1,769
| +20% | +$191K | 0.05% | 191 |
|
|
2019
Q3 | $887K | Buy |
9,059
+1,493
| +20% | +$146K | 0.04% | 201 |
|
|
2019
Q2 | $991K | Buy |
7,566
+3,064
| +68% | +$401K | 0.05% | 189 |
|
|
2019
Q1 | $609K | Sell |
4,502
-1,674
| -27% | -$226K | 0.04% | 170 |
|
|
2018
Q4 | $601K | Sell |
6,176
-2,080
| -25% | -$202K | 0.04% | 173 |
|
|
2018
Q3 | $1.15M | Buy |
8,256
+2,242
| +37% | +$312K | 0.06% | 147 |
|
|
2018
Q2 | $747K | Buy |
6,014
+1,754
| +41% | +$218K | 0.04% | 171 |
|
|
2018
Q1 | $475K | Buy |
4,260
+895
| +27% | +$99.8K | 0.03% | 189 |
|
|
2017
Q4 | $402K | Buy |
3,365
+791
| +31% | +$94.5K | 0.02% | 207 |
|
|
2017
Q3 | $361K | Buy |
2,574
+19
| +0.7% | +$2.67K | 0.02% | 195 |
|
|
2017
Q2 | $311K | Buy |
2,555
+189
| +8% | +$23K | 0.02% | 194 |
|
|
2017
Q1 | $287K | Sell |
2,366
-197
| -8% | -$23.9K | 0.02% | 175 |
|
|
2016
Q4 | $314K | Buy |
2,563
+445
| +21% | +$54.5K | 0.03% | 153 |
|
|
2016
Q3 | $260K | Buy |
2,118
+106
| +5% | +$13K | 0.03% | 172 |
|
|
2016
Q2 | $235K | Sell |
2,012
-136
| -6% | -$15.9K | 0.03% | 172 |
|
|
2016
Q1 | $299K | Buy |
+2,148
| New | +$299K | 0.04% | 147 |
|